Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines

Molecular Cancer Research

Volumn 4, Issue 4, 2006, Pages 235-246

  Xu, Guoxiong ^a   Zhou, Hong ^a   Wang, Qinghua ^b   Auersperg, Nelly ^c   Peng, Chun ^a  

^a YORK UNIVERSITY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 7; ADENOVIRUS VECTOR; CASPASE 3; DNA NUCLEOTIDYLEXOTRANSFERASE; GROWTH FACTOR RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; NICK END LABELING; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ACTIVIN RECEPTORS, TYPE I; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA; CASPASE 3; CASPASES; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HUMANS; OVARIAN NEOPLASMS; OVARY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFECTION; UP-REGULATION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

ADENOVIRIDAE;

EID: 33646128737     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-05-0174     Document Type: Article

References (48)

1. Barnes MN, Grizzle WE, Grubbs CJ, Partridge EE. Paradigms for primary prevention of ovarian carcinoma. CA Cancer J Clin 2002;52:216-25.
2. Moss C, Kaye SB. Ovarian cancer: progress and continuing controversies in management. Eur J Cancer 2002;38:1701-7.
3. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
4. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49:33-64.
5. Massagué J, Chen Y-G. Controlling TGF-β signaling. Genes Dev 2000; 6:627-44.
6. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev 2002;23:787-823.
7. Peng C. The TGF-β superfamily and its roles in the human ovary and placenta. J Obstet Gynaecol Can 2003;25:834-44.
8. Narayan S, Thangasamy T, Balusu R. Transforming growth factor-β receptor signaling in cancer. Front Biosci 2005;10:1135-45.
9. Choi KC, Kang SK, Tai CJ, Auersperg N, Leung PC. The regulation of apoptosis by activin and transforming growth factor-β in early neoplastic and tumorigenic ovarian surface epithelium. J Clin Endocrinol Metab 2001; 86:2125-35.
10. Dunfield LD, Dwyer EJ, Nachtigal MW. TGF β-induced Smad signaling remains intact in primary human ovarian cancer cells. Endocrinology 2002; 143:1174-81.
11. Hurteau J, Rodriguez GC, Whitaker RS, et al. Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 1994;74:93-9.
12. Shepherd TG, Nachtigal MW. Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology 2003;144:3306-14.
13. Brennan J, Norris DP, Robertson EJ. Nodal activity in the node governs left-right asymmetry. Genes Dev 2002;16:2339-44.
14. Nonaka S, Shiratori H, Saijoh Y, Hamada H. Determination of left-right patterning of the mouse embryo by artificial nodal flow. Nature 2002;418:96-9.
15. Xu G, Zhong Y, Munir S, Yang BB, Tsang BK, Peng C. Nodal induces apoptosis and inhibits proliferation in human epithelial ovarian cancer cells via activin receptor-like kinase 7. J Clin Endocrinol Metab 2004;89:5523-34.
16. Attisano L, Wrana JL. Signal transduction by the TGF-β superfamily. Science 2002;296:1646-7.
17. ten Dijke P, Hill CS. New insights into TGF-β-Smad signalling. Trends Biochem Sci 2004;29:265-73.
18. Rydén M, Imamura T, Jornvall H, et al. A novel type I receptor serine/ threonine kinase predominantly expressed in the adult central nervous system. J Biol Chem 1996;271:30603-9.
19. Tsuchida K, Sawchenko PE, Nishikawa SI, Vale WW. Molecular cloning of a novel type I receptor serine/threonine kinase for the TGF-β superfamily from rat brain. Mol Cell Neurosci 1996;7:467-78.
20. Bondestam J, Huotari MA, Moren A, et al. cDNA cloning, expression studies and chromosome mapping of human type I serine/threonine kinase receptor ALK7 (ACVR1C). Cytogenet Cell Genet 2001;95:157-62.
21. Roberts JR, Hu S, Qiu Q, et al. Identification of novel isoforms of activin receptor-like kinase 7 (ALK7) generated by alternative splicing and expression of ALK7 and its ligand, Nodal, in human placenta. Biol Reprod 2003;68:1719-26.
22. Reissmann E, Jornvall H, Blokzijl A, et al. The orphan receptor ALK7 and the activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev 2001;15:2010-22.
23. Tsuchida K, Nakatani M, Yamakawa N, Hashimoto O, Hasegawa Y, Sugino H. Activin isoforms signal through type I receptor serine/threonine kinase ALK7. Mol Cell Endocrinol 2004;220:59-65.
24. Jörnvall H, Blokzijl A, ten Dijke P, Ibanez CF. The orphan receptor serine/ threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line. J Biol Chem 2001;276:5140-6.
25. Kim BC, Van Gelder H, Kim TA, et al. ALK7 induces apoptosis through activation of MAP kinases in a Smad3-dependent mechanism in hepatoma cells. J Biol Chem 2004;279:28458-65.
26. Munir S, Xu G, Wu Y, Yang BB, Lala K, Peng C. Nodal and activin receptor-like kinase (ALK) 7 inhibit proliferation and induce apoptosis in human trophoblast cells. J Biol Chem 2004;279:31277-86.
27. Debatin K-M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 2004;53:153-9.
28. Schultz DR, Harrington WJ, Jr. Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 2003;32:345-69.
29. Holcik M, Gibson H, Korneluk RG. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 2001;6:253-61.
30. Breckenridge DG, Xue D. Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. Curr Opin Cell Biol 2004;16:647-52.
31. L protein by caspase-3-like proteases. Oncogene 1998;17:1295-304.
32. Rowan S, Fisher DE. Mechanisms of apoptotic cell death. Leukemia 1997; 11:457-65.
33. Suzuki M, Youle RJ, Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 2000;103:645-54.
34. Fesik AW. Insights into programmed cell death through structural biology. Cell 2000;103:273-82.
35. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-32.
36. Asselin E, Mills GB, Tsang BK. XIAP regulated Akt activity and caspase-3-depentent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cells. Cancer Res 2001;61:1862-8.
37. Shima Y, Nakao K, Nakashima T, et al. Activation of caspase-8 in transforming growth factor-β-induced apoptosis of human hepatoma cells. Hepatology 1999;30:1215-22.
38. Shooner C, Caron PL, Fréchette-Frigon G, Leblanc V, Déry Dery MC, Asselin E. TGF-β expression during rat pregnancy and activity on decidual cell survival. Reprod Biol Endocrinol 2005;3:20-37.
39. Gottfried Y, Rotem A, Lotan R, Steller H, Larisch S. The mitochondrial ARTS protein promotes apoptosis through targeting XIAP. EMBO J 2004; 23:1627-35.
40. Yamaguchi K, Nagai S, Ninomiya-Tsuji J, et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TABI-1 in the BMP signaling pathway. EMBO J 1999;18:179-87.
41. Reffey SB, Wurthner JU, Parks WT, Roberts AB, Duckett CS. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-β signaling. J Biol Chem 2001;276:26542-9.
42. Lewis J, Burstein E, Reffey SB, Bratton SB, Roberts AB, Duckett CS. Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis. J Biol Chem 2004;279:9023-9.
43. Yamada SD, Baldwin RL, Karlan BY. Ovarian carcinoma cell cultures are resistant to TGF-β1-mediated growth inhibition despite expression of functional receptors. Gynecol Oncol 1999;75:72-7.
44. Di Simone N, Crowley WF, Jr., Wang QF, Sluss PM, Schneyer AL. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 1996;137:486-94.
45. Choi KC, Kang SK, Nathwani PS, Cheng KW, Auersperg N, Leung PC. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE). Mol Cell Endocrinol 2001;174:99-110.
46. Sánchez-Capelo A. Dual role for TGF-β1 in apoptosis. Cytokine Growth Factor Rev 2005;16:15-34.
47. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998; 95:2509-14.
48. Xu G, Chakraborty C, Lala PK. Expression of TGF-β signalling genes in the normal, premalignant, and malignant human trophoblast: loss of Smad3 in choriocarcinoma cells. Biochem Biophys Res Commun 2001; 287:47-55.